Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Hydroxyapatite (MCHC) vs Vitamin D3: Vitamin D3 has the stronger overall evidence (7.5 vs 4.5/10); they work on different things and are often used together, not either/or. Take the 2-minute quiz for a pick tailored to your goals.
Vitamin D3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Mixed
8 of 17 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Hydroxyapatite (MCHC) and Vitamin D3 have evidence — compare verdict strength side-by-side.
No matched minimum effective dose established here
Use the labelled elemental calcium amount when counting calcium intake, rather than the weight of the whole compound. Include calcium from food and other supplements.
Split doses with meals, Morning and evening
Ossein-hydroxyapatite compound tablets
2000-4000 IU daily
Morning with breakfast
D3 (cholecalciferol) softgel or liquid
and 7 more not shown
and 1 more not shown
Calcium with vitamin D is the combination tested in the osteoporosis trials. Those trials do not show that hydroxyapatite works better than other calcium forms with vitamin D, or that everyone with a bone health goal needs both.
Recommendation: May be useful when calcium or vitamin D intake is inadequate. No specific hydroxyapatite synergy is established. Count the calcium and the vitamin D from all products toward one daily total each. This applies to vitamin D3, not to active vitamin D drugs such as calcitriol or alfacalcidol, which need a prescriber.
12-36 months
N/A
Hours to 3 months
5-6 months
4-8 weeks
4-8 weeks
2-4 weeks
4-8 weeks
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.
Menopause (2009) · Meta-Analysis
Meta-analysis of randomised controlled trials comparing ossein-hydroxyapatite complex (OHC) with calcium carbonate, not with placebo. Of 18 controlled trials identified, 6 were pooled in a random-effects model, and the abstract does not give the total number of participants.
Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.
Osteoporos Int (1995) · RCT · n=40
Randomised, double-masked trial in 40 women with postmenopausal osteoporosis, each given 1,400 mg calcium a day as either OHC or calcium carbonate for 20 months.
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Clin Drug Investig (2011) · RCT · n=120
Randomised, open-label trial in 120 women over 65 with osteoporosis (55 OHC, 65 calcium carbonate), of whom 54 completed 3 years. OHC gave 712 mg elemental calcium a day and calcium carbonate 1,000 mg, and both groups also took calcifediol.
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
Nature communications (2025) · RCT · n=22220
Ancillary analysis of VITAL: 22,220 adults without T2D randomized to vitamin D3 2000 IU/day or placebo, with a meta-analysis of 3 additional trials.
Vitamin D Supplementation for Patients with Dysmenorrhoea: A Meta-Analysis with Trial Sequential Analysis of Randomised Controlled Trials
Nutrients (2024) · Meta-Analysis · n=687
TSA revealed that the current RCTs provide sufficient information.
Vitamin D and respiratory tract infections
BMJ (2017) · Meta-Analysis · n=11321
25 RCTs, 11 321 participants aged 0 to 95 years. Vitamin D reduced acute respiratory tract infection overall (adjusted OR 0.88, 95% CI 0.81 to 0.96).
One pooled estimate across the trials and doses shown. Ambulatory or institutionalised people aged 60 or over, double-blind cholecalciferol RCTs, with or without calcium, vs calcium or placebo. Strata pool different trials. Source: PMID 15886381.
One pooled estimate across the trials and doses shown. Ambulatory or institutionalised people aged 60 or over, double-blind cholecalciferol RCTs, with or without calcium, vs calcium or placebo. Strata pool different trials. Source: PMID 15886381.
Both points come from a meta-analysis of double-blind cholecalciferol trials in people aged 60 and over (PMID 15886381). Trials at 700 to 800 IU a day cut hip fracture risk by 26% (RR 0.74) and non-vertebral fractures by 23%, plotted at 800 IU. Trials at 400 IU a day showed no benefit (hip fracture RR 1.15), and the WHI trial of 400 IU with 1,000 mg calcium did not significantly reduce hip fracture (PMID 16481635). Most of these trials also gave calcium, and the Cochrane review found vitamin D alone unlikely to prevent fractures while vitamin D with calcium gave a small reduction (PMID 24729336). Doses above 800 IU were not compared, so no optimal dose or ceiling is set.
Vitamin D3 has a higher evidence score (7.5/10 vs 4.5/10) and wins in 3 of 3 categories.
For bone health, Vitamin D3 has a higher relevance score (92 vs 55).
Hydroxyapatite (MCHC) and Vitamin D3 may work well together: Calcium with vitamin D is the combination tested in the osteoporosis trials. Those trials do not show that hydroxyapatite works better than other calcium forms with vitamin D, or that everyone with a bone health goal needs both. May be useful when calcium or vitamin D intake is inadequate. No specific hydroxyapatite synergy is established. Count the calcium and the vitamin D from all products toward one daily total each. This applies to vitamin D3, not to active vitamin D drugs such as calcitriol or alfacalcidol, which need a prescriber.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
Berberine, inositol, magnesium vs the cinnamon/chromium hype — and the med-interaction warning.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.